When was Oertli Instrumente founded?

Oertli Instrumente was founded in 1955.

Where is Oertli Instrumente located?

Oertli Instrumente is headquartered in Berneck, Switzerland.

How many employees does Oertli Instrumente have?

As of Jul 31, 2026, the latest employee count at Oertli Instrumente is 176.

Where does Oertli Instrumente rank among its competitors?

Oertli Instrumente ranks 5th amongst 75 active competitors, of which 10 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was IRIDEX, which secured $10M in Mar, 2025.

Who are the top competitors of Oertli Instrumente?

Oertli Instrumente's top competitors include Perfuse Therapeutics, IRIDEX and MicroSurgical Technology. Among them, IRIDEX secured the most recent funding round in March, 2025.

Oertli Instrumente - 2026 Company Profile & Competitors

Company Details

Oertli has developed a portfolio of ophthalmology medical device. The instruments developed include glaucoma tip, incision template, drainage bag, trocar systems, continuous flow cutter, bipolar forceps, tip eraser, diathermy tip, bimanual instrument kits, infusion line, irrigation sleeve, capsulotomy plug-on tip, etc. The company focuses on the areas of cataract surgery, glaucoma surgery or vitrectomy.

Website: www.oertli-instruments.com/en-us
Email ID: *****@oertli-instruments.com
Phone Number: +41 **********

Key Metrics

Founded Year

1955

Location

Berneck, Switzerland

Stage

Unfunded

Ranked

5^th among 75 active competitors

Employee Count

176 as on Jul 31, 2026

Similar Companies

Perfuse Therapeutics & 85 more

View Oertli Instrumente's full profile

Oertli Instrumente has not raised any funding rounds yet.

Oertli Instrumente's employee count trend

Oertli Instrumente has 176 employees as of Jul 26. Here is Oertli Instrumente's employee count trend over the years:

Employee count trend for Oertli Instrumente

Uncover Oertli Instrumente's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Oertli Instrumente include Perfuse Therapeutics, IRIDEX and MicroSurgical Technology. Here is the list of Top 10 competitors of Oertli Instrumente, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Perfuse Therapeutics 2018, San Francisco (United States), Acquired	Developer of therapies to treat eye disorders	-	Access Industries, Lilly Asia Ventures & 3 others	49/100
2nd	IRIDEX 1989, Mountain View (United States), Public	Manufacturer of ophthalmic laser systems and surgical instruments for eyes	-	Incubic, Technology Partners & 1 others	47/100
3rd	MicroSurgical Technology 1976, Redmond (United States), Acquired	Develops a portfolio of Surgical tools for Ophthalmic surgeries	-	-	47/100
4th	Dopavision 2017, Berlin (Germany), Series A	Developer of a digital therapeutic for myopia	$17.4M	Boehringer Ingelheim Venture Fund, Seventure Partners ... & 9 others	45/100
5th	Oertli Instrumente 1955, Berneck (Switzerland), Unfunded	Developer of ophthalmology medical device	-	-	44/100
6th	Keeler 1917, Windsor (United Kingdom), Unfunded	A portfolio of ophthalmic devices	-	-	44/100
7th	Lalji International 2018, Ahmedabad (India), Unfunded	Manufacturer of disposable medical drapes and surgical gowns. The company produces a variety of products for various medical applications, including ophthalmology, gynecology, and general surgery. These products are designed for single-use and contribute to maintaining a sterile environment during procedures. The manufacturing process emphasizes quality control to ensure the safety and efficacy of the products. The company's offerings also include hospital beds and related furniture.	-	-	42/100
8th	Lamellar 2007, Glasgow (United Kingdom), Series C	Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies	$18.4M	Hambro Perks, Invesco & 4 others	42/100
9th	Ziemer Ophthalmology 2005, Basel (Switzerland), Series B	Portfolio of devices for refractive and corneal surgery	$17.4M	BV Partners, HBM Partners & 1 others	40/100
10th	Katena 1975, Tampa (United States), Acquired	Ophthalmic surgical products for sight restoration, clinician support, and patient care	$7.5M	Audax Private Equity	40/100